ATXI - Kapitalisasi marang volume dodolan Avenue Therapeutics Inc.

Logo korporat perusahaan Avenue Therapeutics Inc. (ATXI)

Avenue Therapeutics possesses the prospect of premium pricing power driven by its safe drug portfolio. On GURU.Markets, the company's rolling P/S ratio reflects a market valuation where the mark characterizes this parameter. The business relies on the development of non-addictive IV Tramadol for clinics, while an intensive R&D pipeline focuses on molecules targeting tremors and acute nervous system conditions.

ATXI: Multiplikator P/S Avenue Therapeutics, Inc 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Avenue Therapeutics Inc (ATXI)

Analisis fundamental perusahaan:Avenue Therapeutics, Inc. - ATXI
Produk dadi Avenue Therapeutics, Inc

The ratio of market capitalization to annual revenue measures the premium the market is willing to pay per unit of operating income, reflecting the level of confidence in future cash flows. For Avenue Therapeutics (ATXI), which is in the early stages of CNS development, the company's average P/S reflects a speculative valuation of clinical phase expectations, where sharp fluctuations on the chart signal the risk of overpaying at peaks.

Perusahaan pesaing

BIIB (Biogen) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NBIX (Neurocrine Corp)|Regencell Bioscience - Rasio rega marang pendapatan|Axsome Therapeutics - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Rasio rega marang pendapatan|Rega marang dodolan Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - Multiplikator P/S|CPRX: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S DNLI|Koefisien rega marang pendapatan Harmony Biosciences|Biohaven Ltd - Kapitalisasi marang pendapatan|Multiplikator P/S Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Praxis Corp PRAX|AVXL: Multiplikator P/S|CBLL (ceribell.com) - Rasio rega marang pendapatan|PRTA (Prothena Corporation) - Multiplikator P/S|Kapitalisasi marang pendapatan alector.com (ALEC)|Rasio rega marang pendapatan Annexon, Inc. (ANNX)|OMER - Rega marang dodolan|Multiplikator P/S NGNE (Neurogene Inc)|AC Immune (ACIU) - Rega marang dodolan|Voyager Therapeutics Inc - Multiplikator P/S|Neumora (NMRA) - Kapitalisasi marang pendapatan|SCLX: Multiplikator P/S|TVGN - Koefisien rega marang pendapatan|ACOG (Alpha Cognition Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan cogrx.com (CGTX)|Rasio rega marang pendapatan Inhibikase Therapeutics Inc (IKT)|Koefisien rega marang pendapatan Cassava Sciences|Multiplikator P/S ASRT (Assertio Holdings)|COYA - Kapitalisasi marang pendapatan|vistagen.com - Multiplikator P/S|OVID: Rasio rega marang pendapatan|Acumen Pharmaceuticals, Inc (ABOS) - Rasio rega marang pendapatan|CervoMed Inc - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alterity Therapeutics Limited|clene.com (CLNN) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan PEPG (PepGen Inc)|Multiplikator P/S jupiterneurosciences.com (JUNS)|Rasio rega marang pendapatan Relmada Therapeutics, Inc. RLMD|ANVS: Rasio kapitalisasi marang pendapatan|Grace Tx - Multiplikator P/S|AIFF (Firefly Neuroscience Inc) - Rasio kapitalisasi marang pendapatan|KLTO: Multiplikator P/S|NeuroSense Therapeutics, Ltd. (NRSN) - Multiplikator P/S|Rasio rega marang pendapatan Reviva Pharmaceuticals, Inc.|Kapitalisasi marang pendapatan metaviatx.com (MTVA)|Multiplikator P/S NRXS|HSDT - Rega marang dodolan|Passage Bio, Inc. - Kapitalisasi marang pendapatan|bionomics.com.au (NEUP) - Rega marang dodolan|Minerva - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ATHA (Athira Pharma Inc)|ADXN: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator P/S|PTIX (Protagenic Therapeutics) - Kapitalisasi marang volume dodolan|Multiplikator P/S KTTA|Koefisien rega marang pendapatan Cortigent|Rasio rega marang pendapatan Brainstorm Cell Therapeutics, Inc. BCLI|Rasio kapitalisasi pasar marang pendapatan CARA|chromocell.com - Multiplikator P/S|Rasio rega marang dodolan ELYM|ITCI: Multiplikator P/S|Rega marang dodolan Longboard Pharmaceuticals, Inc. (LBPH)|Rasio rega marang pendapatan Marinus Pharmaceuticals, Inc.|NKGN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRBO|SAGE: Rasio rega marang dodolan|Synaptogenix Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Multiplikator P/S|Anew Medical (WENA) - Kapitalisasi marang pendapatan|CERE (Cerevel Corp) - Kapitalisasi marang pendapatan